CSE/SE (CSE/SE)

Canadian Securities Exchange: CSE/SE · CAD

CA$0.51

+0.00 (0.0%)· Recorded snapshot

Market cap	6.6M
Net income (ttm)	-33.2K
EPS (ttm)	-CA$0.00
Shares out	12.9M
Volume	2,100
Beta	1.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -33.2K
EPS (ttm): -CA$0.00
Market cap: 6.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-1.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/SE indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

CAD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-23
Enterprise value	CAD 5.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA87039X1179
Last earnings date	2026-02-27
Last refreshed	2026-10-29
Last stock split date	2024-12-11
Last stock split type	Reverse
Market cap	CAD 6.6M
Price	CAD 0.51
Price currency	CAD
Sector	Healthcare
SIC code	8748
Stock price date	2025-06-19
Symbol	cse/SE
Website	https://sweetearthskincare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.5%
FCF / EV yield	-1.06%
FCF yield	-0.95%
Industry forward P/E	34.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profitable quarters	1
ROA	-1.34%
ROA (5Y)	-70.22%
ROCE	79.97%
ROIC	-1.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	240.33%
EPS growth quarters	3
EPS growth years	0
Net income growth (QoQ)	191.17%
Net income growth quarters	2
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -33,240
EPS	CAD -0.00
FCF per share	CAD -0.00
Financing cash flow	CAD -2.5M
Free cash flow	CAD -62,368
Net borrowing	CAD -2.7M
Net cash flow	CAD -2.6M
Net income	CAD -33,240
Operating income	CAD -33,240

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.00
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD 252,596
Net cash / market cap	3.83%
Net cash growth	115.53%
Piotroski F-Score	0
Shareholders' equity	CAD -41,566
Tangible book value	CAD -41,566
Tangible book value per share	CAD -0.00
Total assets	CAD 252,596
Total cash	CAD 252,596
Total debt	CAD 0
Total liabilities	CAD 294,162
WACC	10.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 252,596
Current liabilities	CAD 294,162
Current ratio	0.86
Net working capital	CAD -294,162
Quick ratio	0.86
Working capital	CAD -41,566

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-94.54%
Shareholder yield	-94.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.58
1D price change	0%
1M price change	13.33%
1M total return	13.33%
1W price change	-1.92%
1W total return	-1.92%
1Y price change	13.33%
1Y return CAGR	13.34%
1Y total return	13.33%
20-day SMA	CAD 0.54
200-day SMA	CAD 0.96
3M price change	-8.93%
3M total return	-8.93%
3Y price change	-93.63%
3Y return CAGR	-60.04%
3Y total return	-93.63%
50-day SMA	CAD 0.40
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.74
52-week high date	2025-06-02
52-week low	CAD 0.10
52-week low date	2024-09-17
5Y price change	-99.35%
5Y return CAGR	-63.44%
5Y total return	-99.35%
6M price change	168.42%
6M total return	168.42%
All-time high	CAD 186.00
All-time high date	2021-02-11
All-time low	CAD 0.10
All-time low date	2024-09-16
Average true range (ATR)	CAD 0.07
Average volume	12.2K
Beta (1Y)	0
Beta (2Y)	0.07
Beta (5Y)	1.17
Change from 52-week high	-31.08%
Change from 52-week low	410%
Change from all-time high	-99.73%
Change from all-time low	410%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 1,071
High price	CAD 0.51
Low price	CAD 0.51
Monthly RSI	35.98
Open price	CAD 0.51
Previous close	CAD 0.51
Price vs 150-day SMA	-11.37%
Price vs 20-day SMA	-5.87%
Price vs 200-day SMA	-46.98%
Price vs 50-day SMA	29.05%
Relative volume	0.17
RSI	51.46
Sharpe ratio	2.07
Sortino ratio	5.13
Volume	2.1K
Weekly RSI	43.25
YTD price change	27.5%
YTD total return	27.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	-38.79%
Shares change (YoY)	94.54%
Shares outstanding	12.9M

Deeper analysis on CSE/SE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/SE report

Is a complete CSE/SE research report available?

No complete published report is available for cse/SE (CSE/SE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/SE (CSE/SE)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/SE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/SE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/SE

Frequently asked questions